Creative Planning’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$811K Buy
32,394
+4,101
+14% +$97K ﹤0.01% 2631
2025
Q4
$745K Buy
28,293
+979
+4% +$21.4K ﹤0.01% 2511
2025
Q3
$467K Buy
27,314
+1,925
+8% +$27.6K ﹤0.01% 2784
2025
Q2
$319K Buy
25,389
+13,567
+115% +$162K ﹤0.01% 2847
2025
Q1
$141K Buy
11,822
+11,765
+20,640% +$160K ﹤0.01% 3178
2024
Q4
$834 Buy
+57
New +$797 ﹤0.01% 3551

Other funds holding ZYME

Creative Planning's ZYME Position: Q1 2026 in Review

Creative Planning increased its Zymeworks (ZYME) stake by 14% in Q1 2026, buying an estimated $97K and bringing the position to 32,394 shares worth $811K. The position accounts for ﹤0.01% of the portfolio, ranked #2631.

Creative Planning first reported a position in ZYME in Q4 2024 and has held it in 6 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Creative Planning held 32,394 shares of Zymeworks worth $811K as of Q1 2026.
  • Creative Planning bought 4,101 Zymeworks shares in Q1 2026, an estimated $97K.
  • Zymeworks made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2631 holding.
  • Creative Planning first reported a position in Zymeworks in Q4 2024 and has held it in 6 quarters since.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.